Navigation Links
Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
Date:5/18/2009

pport a larger, randomized Phase III study," he says. "This is a Phase II study of this triple combination, so we would need to study this treatment against the standard best two-drug treatment in a randomized Phase III study to know if this triplet is more effective."

"This regimen seems to be a very reasonable choice, and it offers the added advantage that women who use it do not lose their hair," he says. The drug combination used most commonly for patients with HER2+ breast cancer that has spread -- paclitaxel or docetaxel with trastuzumab -- always causes hair loss, Dr. Tan says.

All of the agents are approved for use by the U.S. Food and Drug Administration for cancer, although vinorelbine has not been approved for this particular treatment regimen in the U.S., the researchers say.

Capecitabine chemotherapy is not usually paired with trastuzumab because some studies had suggested it does not offer a synergistic, or additive, benefit. However, Dr. Tan says that newer research has shown the combination is in fact promising.

Among the patients studied, 28 (58 percent) had a partial response, a reduction in the size of the metastatic tumor of more than 30 percent by computed tomography. Four patients had a complete response with no more evidence of metastasized tumors on diagnostic scans, the researchers say.

Average survival was improved when compared historically to traditional treatment, Dr. Tan says. "Normally, survival for metastatic breast cancer is two years," he says. "In this study, average survival was 27 months." He cautioned that these results should be validated in a Phase III study.

"The toxicity was tolerable, no more than is seen with a two-drug regimen," he says. The majority of patients (61 percent) experienced a low white blood count, but only about ten percent of patients had fatigue or other common side effects.

Tan stressed that this
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say
2. Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes
3. Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report
4. Fate Therapeutics Adds Pratik Multani, M.D., M.S., as Vice President Clinical Development to Advance Upcoming Clinical Programs of Stem Cell Modulators
5. InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
6. Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
7. Large clinical trial finds pirfenidone may help lung function in IPF patients
8. Fewer Than One Percent of Infertile Couples Who Need Treatment Receive It - Website to Bridge Gap Between Infertile Couples and Fertility Clinics
9. Cleveland Clinic CIO Named to Federal Advisory Committee on Health Information Technology
10. BioVex To Announce Updated Survival Data From a Phase II Clinical Study of OncoVEX GM-CSF in Metastatic Melanoma at The 2009 American Society of Clinical Oncology Meeting
11. Cigna Medical Group Announces Grand Opening of CareToday Clinic in Anthem, Ariz.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... US Sports Football Camps expands its network ... non-contact specialty camps and one contact football camp. The ... located at Bowie State University and Riverdale Baptist School. ... speed and strength of football athletes. The contact football ... Graves, former quarterback in the Canadian Football League, as ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 As the ... a national shortfall of 90,000 doctors by 2025 is ... Susquehanna Health (SH) is proactively preparing by analyzing ... and patient access. , Several factors including the ... number of insured under the Affordable Care Act and ...
(Date:3/6/2015)... First Choice Emergency Room opened its new ... at 13351 W. Bowles Avenue, Littleton, Colorado and is open ... to provide the highest quality emergency medical care to the ... Choice Emergency Room Littleton. , First Choice Emergency ... Chamber of Commerce and a medical community open house yesterday. ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend Report ... and statistics on one of the nation’s biggest drivers ... Management will discuss key findings from the report in ... Spend,” a complimentary March 19 webinar, managed and moderated ... makes up more than a quarter of total drug ...
(Date:3/6/2015)... NC (PRWEB) March 06, 2015 In a ... of Polish mesothelioma patients reported that shoulder pain was their ... story on its website. Click here to read it ... Warsaw analyzed the medical records of 49 mesothelioma patients ... them reported that it was shoulder pain that first prompted ...
Breaking Medicine News(10 mins):Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2
... of biological pathways could lead to treatments for other ... Researchers have discovered seven common DNA variations that increase ... which links the skin condition and psoriatic arthritis to ... 4 in the open-access journal PLoS Genetics , ...
... 11, 2008) During Wednesdays Satellite Symposium 3: ... (CF) at the International Society of Heart and ... clinicians and researchers discussed some of the unique ... patients with CF. , A highlight of the ...
... April 15, 2008, at, ------------------------------------------------------------------------ ... 10:00 ... Dr. Francesco Bellini,Chairman, President and Chief Executive Officer of Neurochem ... management, cordially invite,you to attend the Company,s Annual and Special ...
... of CNA Leaders, LOS ANGELES, April 11 ... the Service,Employees International Union for targeting CNA/NNOC leaders ... home and in patient care,units at hospitals., ... largest RN union --,demanded SEIU International President Andrew ...
... significantly superior to 16 slice multidetector CT in ... abdominal aortic aneurisms (EVAR), according to a recent ... in Bellinzona, Switzerland. , Endovascular repair of ... treatment to open surgery for many patients. Endoleak ...
... feelings of anxiety, worry, distress and insecurity face a risk ... to a unique study led by a University of Rochester ... not developed for people with these personality traits by the ... Duberstein, Ph.D., professor of psychiatry who led the study. But ...
Cached Medicine News:Health News:Researchers Identify New Genetic Links to Psoriasis 2Health News:Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT 2Health News:Neurochem Annual and Special Meeting of shareholders 2Health News:Neurochem Annual and Special Meeting of shareholders 3Health News:RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors 2Health News:RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors 3Health News:RN Leaders of California Nurses Association/NNOC Demand Andy Stern Immediately Cease SEIU's Harassment and Stalking of Nurses at Home and on Patient Care Floors 4Health News:MRI better than MDCT in detecting endoleaks, study says 2Health News:Personality study shows risk of first depression episode late in life 2
(Date:3/6/2015)... , March 6, 2015  The German Court of Appeal ... LLY ) vitamin regimen patent for Alimta® (pemetrexed disodium) would ... market a dipotassium salt form of pemetrexed in ... 2015. The German Court ruled in favor ... and Company v. Actavis. This decision vacated the prior decision ...
(Date:3/6/2015)... , March 6, 2015  Par Pharmaceutical Companies, ... conference call on Friday, March 13, 2015 at ... operations for the fourth quarter and full year ... and currently makes certain financial information available to ... and Exchange Commission and will make certain other ...
(Date:3/6/2015)... , Alemania, 6 de marzo de 2015 /PRNewswire/ ... soluciones de gestión empresarial de imagen médica, fortalece ... el nombramiento de Randolph Sternberg como ... como director de operaciones. Logo ... Sternberg será responsable de las ventas y ...
Breaking Medicine Technology:German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 2German Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit 3TeraRecon fortalece su posición en EMEA 2TeraRecon fortalece su posición en EMEA 3
... ThermoGenesis Corp. (Nasdaq: KOOL ), a leading ... store adult stem cells, said today it has entered ... 60 BMC (Res-Q) System with BioParadox, Inc., a newly-formed ... Under the agreement, ThermoGenesis is granting BioParadox ...
... U.S. Food and Drug Administration today approved Pradaxa ... and blood clots in patients with abnormal heart ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... 2 million Americans, involves very fast and uncoordinated ...
Cached Medicine Technology:ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 2ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement 3FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation 2
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Cost-effective otoscope with xenon halogen illumination. Polycarbonate molded head. Acrylic viewing window with 3X magnification. Nasal and spreadable specula avaliable....
The Pneumatic Consulting Otoscope provides two viewing lenses for dual observation of the tympanic membrane. Sealed system for pneumnatic otoscopy and rotatable head for left- and right-sided viewin...
... Shandon Cryotome FE and FSE are a ... Electron. The microtome is outside of the ... as well as faster temperature adjustment. Simple, ... Complete temperature controls on the main touch-screen ...
Medicine Products: